This has led to various studies all incorporating PSMA PET/CT as diagnostic imaging like the PEACE V trial (NCT03569241) or the “Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy” study (NCT03160794). The gene discussed is FOLH1; the disease is prostate carcinoma.